TROG Cancer Research
Members Login   CQMS Login

TD 17.04 (NEURONE)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)


Intracranial stereotactic radiosurgery with or without memantine 


The aim of the study is to determine if the addition of memantine will reduce the cognitive decline in patients treated with SRS 

Opening to recruitment

Approximately Quarter 2, 2018

Trial chairperson

Dr Eric Hau, Crown Princess Mary Cancer Centre, Westmead

Trial contact

Rebecca Montgomery
Clinical Trials Project Manager
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910

Trial resources for TROG members

TD 17.04 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.